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A newly developed oligonucleotide array suited for multilocus sequence typing (MLST) of Staphylococcus
aureus strains was analyzed with two strain collections in a two-center study. MLST allele identification for the
first strain collection fully agreed with conventional strain typing. Analysis of strains from the second collection
revealed that chip-defined MLST was concordant with conventional MLST. Array-mediated MLST data were
reproducible, exchangeable, and epidemiologically concordant.
Multilocus sequence typing (MLST) was introduced as a
microbial typing method that generates a portable, binary out-
put (14). The sequences of internal fragments of several house-
keeping genes are determined for each isolate, thereby defin-
ing specific alleles for each locus. The method is highly
discriminatory, and allelic profiles are sufficiently stable. Com-
plete genomes of both eukaryotic and prokaryotic pathogens
and hosts have been sequenced. Based on these data, high-
density oligonucleotide arrays have been developed in parallel.
Applications for array technology include resequencing of clin-
ically relevant genes, monitoring quantitative changes in gene
expression (5), unraveling the organization and control of ge-
netic pathways and genetic locus-specific typing (9). The intro-
duction of high-throughput systems, such as GeneChip tech-
nology (Affymetrix, Santa Clara, Calif.), is a promising
methodology for assessing genetic diversity (11). Affymetrix
systems have been introduced in microbiological research be-
fore (16). The method is based on hybridization of target
nucleic acid to large numbers of oligonucleotides synthesized
in situ on a small glass substrate (8). In the present research
project, two centers determined the feasibility of a Staphylo-
coccus GeneChip for MLST of Staphylococcus aureus (7).
Bacterial strains. The 50 S. aureus strains used for the
present study originated from two separate strain collections.
The first stock culture collection consisted of 20 methicillin-
resistant S. aureus (MRSA) strains that had been well charac-
terized by multiple pheno- and genotyping systems (17, 18)
(see Table 2). The second stock culture collection comprised
30 S. aureus strains (20% MRSA), selected from the MLST
database collection (http://www.mlst.net), with known multilo-
cus sequence types (see Table 3). This strain collection was
sent to both research centers, which were blinded to the strain
identities.
Probe array design and tiling strategy. The Staphylococcus
DNA array identifies sequence variation in seven MLST tar-
gets by using the 4L tiling strategy described previously (16).
Briefly, for every base interrogated within the reference se-
quence, four probes of equal length are synthesized on the
chip. Those four probes are identical except at the interroga-
tion position (centrally located within the probe). Each base is
determined by comparing the signal intensities of the labeled
target for the four probes. A comprehensive database of allele
reference sequences of the seven different housekeeping genes
(http://www.mlst.net) was utilized to design the array. Table 1
summarizes the number of alleles for each gene at the time this
chip was designed. Probe redundancy was eliminated by syn-
thesizing probes shared by two or more allele reference se-
quences only once on the array.
Target preparation. For DNA isolation, bacteria were
grown overnight at 37°C. Three to five individual colonies were
suspended in TEG (25 mM Tris, 10 mM EDTA, 50 mM glu-
cose) buffer containing lysostaphin and incubated at 37°C for
1 h. Staphylococcal DNA was extracted with a QIAamp DNA
minikit (Qiagen, Westburg, Leusden, The Netherlands) ac-
cording to the manufacturer’s protocol. DNA was stored at
20°C until use. DNA was added to the PCR mixture. The
specific primers targeting the seven housekeeping genes were
defined by Enright et al. (7) with exception of the of the arcC
forward primer (4). Multiplex PCR was performed in a Gene-
Amp PCR system 9700 (Applied Biosystems, Nieuwerkerk aan
den IJssel, The Netherlands). Two different protocols were
used for labeling of the PCR products (1). A conventional
labeling strategy, based on transcription with incorporation of
fluorescein-dUTP, was used for strain collection 1. In vitro-
transcribed RNA was chemically fragmented (2). A newly de-
veloped DNA chemical labeling technique (13) (bioMe´rieux,
Marcy l’Etoile, France) was used for strain collections 1 and 2.
The labeling reaction mixture contained PCR product and
labeling reagent (meta-biotin phenylmethyl diazomethyl).
DNA was chemically fragmented and subsequently purified
(QIAquick nucleotide removal kit; Qiagen).
Probe array hybridization and analysis. Hybridization of the
probe arrays was performed with a GeneChip fluidics station
(Affymetrix, St. Clara, Calif.). The fluorescein-labeled RNA
fragments were diluted in hybridization buffer, incubated, and
washed. The chemically labeled, fragmented DNA was dena-
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tured, hybridized with the probe array, and washed, and the
hybrids were stained with streptavidin–R-phycoerythrin
(Dako, Trappes Cedex, France). The probe array was washed
again. Fluorescent signal emitted by the hybrids was detected
at 530 nm (fluorescein) or 570 nm (phycoerythrin) by using a
GeneArray scanner (Agilent, Palo Alto, Calif.). Probe array
fluorescence intensities, base call scores, sequence determina-
tions, and reports were generated by functions available on the
GeneChip software (Affymetrix). The percentage base-right
score was determined by the percentage homology between the
experimentally derived sequence and the distinct reference
sequence tiled on the array.
Table 2 summarizes typing results from both centers ob-
tained for the first S. aureus collection. Labeling of the DNA
samples was achieved by transcription with incorporation of
fluorescein-dUTP (Table 2, method A). Overall, a relatively
low base call score (range, 54.6 to 99.6%; average, 86.7%; data
not shown) was observed in both centers, resulting in discrep-
ant allele identification for the strains in both centers. MLST
probing of strains W1 to W5, defined as identical strains, re-
sulted in identical sequence types. The closely related strains
W6 to W10 were classified as identical with MLST probing.
The sequence types of epidemiologically unique strains W11 to
W20 were diverse except for strains W13 and W16. A new
direct labeling protocol (method B) was used in one center for
retyping the first strain collection with the MLST probing ap-
proach, and no discrepant results were observed between cen-
ters. Moreover, the query sequences were highly correct, as
reflected by the high base-right scores (average score, 98.7%;
range, 83.5 to 100%).
The same chemical labeling protocol was applied for the
second strain collection in both centers. The results of MLST
probing and conventional sequence typing are outlined in Ta-
ble 3. The vast majority of the query sequences matched per-
fectly with the allele type of the reference sequence from the
GeneChip database, as shown by a high base-right score in
both centers (average scores in centers 1 and 2, 99.2 and
99.6%, respectively; data not shown). In center 1, only one
discordant result (strain 19) was observed. The reason was that
the C residue normally present at position 249 of the glpF allele
6 fragment was misinterpreted as a G residue in the derived
sequence. This led to a shift from glpF allele 6 to 16. Since tpi
allele type 49, as obtained for strain 21 by conventional MLST,
was not present in the GeneChip database, both centers mis-
classified this gene fragment (tpi allele type 3). The difference
between the alleles is a replacement of a C with a G residue,
that refers to alleles 3 and 49, respectively, at nucleotide
position 158 of the tpi gene fragment (MLST website [http:
//www.mlst.net]). The probing results showed a G residue on
TABLE 1. GeneChip MLST database for the seven
housekeeping genes
Gene (product) Sequencelength (bp)
No. of alleles
considered
for
GeneChip
design
arcC (carbamate kinase) 456 20
aroE (shikimate dehydrogenase) 456 33
glpF (glycerol kinase) 465 18
gmk (guanylate kinase) 429 18
pta (phosphate acetyl transferase) 474 19
tpi (triosephosphate isomerase) 402 25
yqiL (acetylcoenzyme A acetyltransferase) 516 29
TABLE 2. Comparison of MLST GeneChip results obtained from two centers with conventional pheno- and genotyping data
for S. aureus strain collection 1a
Strain
code
Result of conventional technique
MLST StaphChip result
Center 1 Center 2 (labeling
method A)Labeling method A Labeling method B
PFGE
TAR916/
SHIDA
type
RAPD Phage type Binary type Allelic profile ST Allelic profile ST Allelic profile ST
W1 A A AAA 77 001010011111 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247
W2 A A AAA 77 001010011111 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247
W3 A A AAA 77 001010011111 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247
W4 A A AAA 77 001010011111 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247
W5 A A AAA 77 001010011111 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247
W6 B B BBB NT 000110011111 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45
W7 B1 B BBB 95 000010001111 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45
W8 B2 B BBB 80 000010001111 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45
W9 B3 B BBB 80 000010011111 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45
W10 B4 B BBB NT 000110011111 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45 10-14-8-6-10-3-2 45
W11 C A CAA 75, 77, 84, 84a, 994 001111011111 3-32-6-1-4-4-3 Unknown 3-32-1-1-4-4-3 81 3-32-1-1-4-4-3 81
W12 D C DCC 6, 81 011111011111 1-4-1-4-12-1-10 5 1-4-1-4-12-1-10 5 1-4-1-4-12-1-10 5
W13 E D EAD 6, 47, 77, 83a, 85, 994 001110011111 2-3-1-1-4-4-3 239 2-3-1-1-4-4-3 239 2-3-1-1-4-4-3 239
W14 F E FDE 85 000010011111 1-1-1-1-1-1-1 1 1-1-1-1-1-1-1 1 1-1-1-1-1-1-1 1
W15 G F ECF 85 001011011111 1-4-1-4-12-1-29 Unknown 1-4-1-4-12-24-29 228 1-4-1-4-12-24-29 228
W16 H G GAD 6, 47, 66 011110011111 2-3-1-1-4-4-3 239 2-3-1-1-4-4-3 239 2-3-1-1-4-4-3 239
W17 I H HAE 75, 77 101110011111 3-3-1-1-4-4-16 250 3-3-1-12-4-4-16 247 3-3-1-12-4-4-16 247
W18 J A HAA 47, 54, 75, 77, 84, 85, 812 000110011111 3-1-1-1-1-5-3 97 3-1-1-1-1-5-3 97 3-1-1-1-1-5-3 97
W19 K I IBG 29, 52, 77 000110011111 2-2-2-2-6-3-2 30 2-2-2-2-6-3-2 30 2-2-2-2-6-3-2 30
W20 L J FAI 29 110110011111 1-4-1-4-12-24-29 228 1-4-1-4-12-24-29 228 1-4-1-4-12-24-29 228
a Abbreviations: PFGE, pulsed-field gel electrophoresis; TAR916 SHIDA, transposon 916, Shine Dalgamo; RAPD, randomly amplified polymorphic DNA analysis
(ERIC2, AP1, and AP7 primers); ST, sequence type; NT, not typeable. Bold indicates a major discrepant result.
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this position, and for that reason, the sequence should have
been classified as allele type 49.
The MLST technique is based on the sequence analysis of
internal fragments of bacterial housekeeping genes (14).
MLST not only has been applied to molecular characterization
of a variety of pathogenic microorganisms (2, 7) but also has
been used for population genetics purposes (4). MLST results
are electronically transferable between different centers, per-
mitting the establishment of international databases via the
Internet (3, 14).
The microbiological importance of high-density DNA probe
array technology has been demonstrated in Mycobacterium
species identification and antibiotic resistance determination
(16) and identification of agr- and sarA-regulated S. aureus
genes by transcription profiling (6). Diverse elements that have
been identified in the staphylococcal genome can be addressed
as potential targets for the development of probes (10, 14, 15,
18–20) and scanned for genetic variability by using DNA chips.
The release of seven S. aureus whole-genome sequences (1, 12)
(The Institute for Genomic Research, University of Okla-
homa, Sanger Center, Trinity College, and the Wellcome Trust
Centre for Epidemiology and Infectious Diseases) generated a
large number of additional nucleic acid targets and, most prob-
ably, additional candidate loci for the epidemiological charac-
terization of MRSA.
The present study describes the application of DNA probe
arrays for MLST-based S. aureus strain discrimination (7).
Oligonucleotide probes, immobilized on the GeneChip, scan
every single nucleotide of these target sequences, identify the
matching allele of each housekeeping gene, and, finally, define
the allelic profile of each isolate. The feasibility of the Gene-
Chip array was determined using two separate strain collec-
tions. In the first phase of the study, amplified and transcribed
DNA of a well-characterized set of MRSA strains was labeled
with a classic fluorochrome. The probing data obtained from
two centers confirmed the epidemiological relatedness of the
strains, as defined with pheno- and genotyping data. However,
single mismatches of the query sequences with the reference
sequence were detected, which led to differences in allele iden-
tification, mostly in combination with suboptimal hybridization
signals. Overall, this resulted in nonoptimal reproduction be-
tween centers, although the epidemiological relatedness of the
strains was established correctly. The second phase of this
study involved the implementation of a new labeling technique.
This approach resulted in excellent reproducibility of the data
when the two centers were considered and showed agreement
with the conventional MLST data.
In conclusion, MLST using high-density DNA arrays is re-
producible, exchangeable, and epidemiologically concordant
and is validated by conventional MLST. This technique pro-
vides an adequate tool for high-throughput genotyping of S.
aureus, especially in national reference centers, where rigorous
quality control procedures can be implemented, allowing the
efficient tracking of staphylococcal clones locally, nationally,
and internationally.
TABLE 3. GeneChip results obtained from S. aureus strain collection 2 in two centers, compared with “classic” MLST data (7)a
Strain
code
MLST StaphChip allelic profilea
ST Allelic profile Center 1 Center 2
1 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
2 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
3 59 19-23-15-2-19-20-15 19-23-15-2-19-20-15 19-23-15-2-19-20-15
4 36 2-2-2-2-3-3-2 2-2-2-2-3-3-2 2-2-2-2-3-3-2
5 15 13-13-1-1-12-11-13 13-13-1-1-12-11-13 13-13-1-1-12-11-13
6 22 7-6-1-5-8-8-6 7-6-1-5-8-8-6 7-6-1-5-8-8-6
7 97 3-1-1-1-1-5-3 3-1-1-1-1-5-3 3-1-1-1-1-5-3
8 1 1-1-1-1-1-1-1 1-1-1-1-1-1-1 1-1-1-1-1-1-1
9 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
10 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
11 40 2-2-2-2-6-2-2 2-2-2-2-6-2-2 2-2-2-2-6-2-2
12 7 5-4-1-4-4-6-3 5-4-1-4-4-6-3 5-4-1-4-4-6-3
13 9 3-3-1-1-1-1-10 3-3-1-1-1-1-10 3-3-1-1-1-1-10
14 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
15 31 2-2-2-3-6-3-2 2-2-2-3-6-3-2 2-2-2-3-6-3-2
16 12 1-3-1-8-11-5-11 1-3-1-8-11-5-11 1-3-1-8-11-5-11
17 25 4-1-4-1-5-5-4 4-1-4-1-5-5-4 4-1-4-1-5-5-4
18 37 2-2-2-2-15-3-2 2-2-2-2-15-3-2 2-2-2-2-15-3-2
19 121 6-5-6-2-7-14-5 6-5-16-2-7-14-5 6-5-6-2-7-14-5
20 45 10-14-8-6-10-3-2 10-14-8-6-10-3-2 10-14-8-6-10-3-2
21 57 2-2-2-2-6-49-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
22 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
23 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
24 45 10-14-8-6-10-3-2 10-14-8-6-10-3-2 10-14-8-6-10-3-2
25 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
26 32 2-12-2-2-6-3-2 2-12-2-2-6-3-2 2-12-2-2-6-3-2
27 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
28 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
29 30 2-2-2-2-6-3-2 2-2-2-2-6-3-2 2-2-2-2-6-3-2
30 38 2-2-10-2-3-3-2 2-2-10-2-3-3-2 2-2-10-2-3-3-2
a ST, sequence type. The number of errors per allele was two for center 1 and one for center 2. Bold indicates a major discrepant result.
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